Dr. Éric A. Cohen Advisor

Éric Cohen, Ph.D. is head of the Laboratory of Human Retrovirology at the Montreal Clinical Research Institute (IRCM) and Professor of Virology at the Université de Montréal.  He is also Lead Investigator of the Canadian HIV Cure Enterprise, CanCURE, a multidisciplinary research consortium dedicated to the study of long-lived HIV reservoirs and the development of …Lire la suite

Luc Tanguay

Mr. Luc Tanguay has a long-standing experience and an enviable reputation in the finance and biotechnology sectors. Named President and Chief Executive Officer in 2012, he has been central to the strategy to buy back rights to EGRIFTA® in 2014, which allowed the Corporation to build its commercial platform. Since 1996, Mr. Tanguay has held …Lire la suite

Conor Walshe

Mr. Walshe is based at the Theratechnologies European head office in Dublin, Ireland. Prior to joining our European subsidiary, Mr. Walshe was General Manager and Vice President, Operations and Commercial, at Aralez Plc. Prior to Aralez Plc, Mr. Walshe spent more than 15 years in the pharmaceutical industry including at Perrigo Plc, Elan Plc and …Lire la suite

Dr. Richard Béliveau Consultant

Richard Béliveau, Ph.D. in Biochemistry, is Scientific Director of the Chair in Prevention and Treatment of Cancer of the Université du Québec à Montréal.   He was Professor of Surgery and Physiology at Université de Montréal and held the Chair of Neurosurgery of the CHUM. He is an associate researcher at the Cancer Prevention Center …Lire la suite

Christian Marsolais

Dr.Christian Marsolais has over 25 years of experience in the research, development and commercialization of new drugs. He started his career in international pharmaceutical companies, including Sandoz, Biochem and Pfizer, where he held different positions from medical advisor to director clinical research and medical affairs. He was also appointed to the global oncology team at …Lire la suite